Our innovation

  • Our innovation

CardioDyn: Redefining Temporary Cardiac Support



Developed by Bypa Medical Solutions, CardioDyn is the first truly physiological, pulsatile, and self-regulated temporary cardiac assist device. Driven by a real-time controller and synchronized with the ECG, it instantly adjusts flow and pressure through its sensors, providing hemodynamic support tailored to the patient's needs. 

Its exclusive and patented innovations enable early, rapid, and critical intervention in patients with acute heart failure, significantly improving survival and prognosis. Both intelligent, easy to use, and less deleterious, CardioDyn opens a new era in emergency cardiovascular care and sets an unprecedented standard of effectiveness in interventional cardiology.

Driven by Medical Authority. Validated by Clinical Excellence.


CardioDyn transcends the concept of a mere innovative device; it embodies a transformative, practical solution addressing a critical global public health imperative. Our unwavering commitment to excellence is reinforced by strategic partnerships with world-renowned hospital institutions, prominently featuring the Pitié-Salpêtrière Hospital in Paris—an undisputed global leader in advanced cardiac and thoracic care.

The project benefits from the active endorsement and invaluable clinical expertise of Professor Pascal Leprince, a distinguished Head of the Department of Thoracic and Cardiovascular Surgery, and Dr. Guillaume Lebreton, the esteemed Head of Clinic at this globally recognized institution. Their direct involvement underscores the scientific rigor and medical credibility foundational to CardioDyn's development.